Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bare

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Virology|August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymusR D Berkowitz, A B van't Wout, N A Kootstra, et al.
Physical Therapy|March 3, 2004
Identification of individuals with patellofemoral pain whose symptoms improved after a combined program of foot orthosis use and modified activity: a preliminary investigationThomas G Sutlive, Scott D Mitchell, Stephanie N Maxfield, et al.
Journal of Virology|November 13, 1998
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivoR D Berkowitz, S Alexander, C Bare, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv miceC A Stoddart, M E Moreno, V D Linquist-Stepps, et al.
Physical Therapy|July 1, 1996
Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrationsA C Bare, M B McAnaw, A E Pritchard, et al.
Environmental Science & Technology|September 27, 2016
Conceptual Framework To Extend Life Cycle Assessment Using Near-Field Human Exposure Modeling and High-Throughput Tools for ChemicalsSusan A Csiszar, David E Meyer, Kathie L Dionisio, et al.
Plos One|August 2, 2007
Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretroviralsCheryl A Stoddart, Cheryl A Bales, Jennifer C Bare, et al.
The Journal of Experimental Medicine|June 22, 1999
Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv miceA Gobbi, C A Stoddart, M S Malnati, et al.
Journal of Virology|August 23, 2000
Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1A Gobbi, C A Stoddart, G Locatelli, et al.
Current Opinion in Toxicology|January 3, 2025
New Approach Methodologies for Exposure ScienceJohn F Wambaugh, Jane C Bare, Courtney C Carignan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Virology|August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymusR D Berkowitz, A B van't Wout, N A Kootstra, et al.
Physical Therapy|March 3, 2004
Identification of individuals with patellofemoral pain whose symptoms improved after a combined program of foot orthosis use and modified activity: a preliminary investigationThomas G Sutlive, Scott D Mitchell, Stephanie N Maxfield, et al.
Journal of Virology|November 13, 1998
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivoR D Berkowitz, S Alexander, C Bare, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv miceC A Stoddart, M E Moreno, V D Linquist-Stepps, et al.
Physical Therapy|July 1, 1996
Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrationsA C Bare, M B McAnaw, A E Pritchard, et al.
Environmental Science & Technology|September 27, 2016
Conceptual Framework To Extend Life Cycle Assessment Using Near-Field Human Exposure Modeling and High-Throughput Tools for ChemicalsSusan A Csiszar, David E Meyer, Kathie L Dionisio, et al.
Plos One|August 2, 2007
Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretroviralsCheryl A Stoddart, Cheryl A Bales, Jennifer C Bare, et al.
The Journal of Experimental Medicine|June 22, 1999
Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv miceA Gobbi, C A Stoddart, M S Malnati, et al.
Journal of Virology|August 23, 2000
Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1A Gobbi, C A Stoddart, G Locatelli, et al.
Current Opinion in Toxicology|January 3, 2025
New Approach Methodologies for Exposure ScienceJohn F Wambaugh, Jane C Bare, Courtney C Carignan, et al.
Pageof 3